|
|
|
In this final instalment of our three-part value-based procurement (VBP) research series, we propose a strategy and recommendations for scaling VBP as a component of value-based...
The Conference Board of Canada | 23 pages |
December 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Dans ce troisième et dernier volet de notre série de travaux de recherche sur l’approvisionnement fondé sur la valeur (AFV), nous proposons une stratégie et des recommandations...
The Conference Board of Canada | 25 pages |
December 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 27 pages |
October 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
|
|
|
|
|
|
|
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 14 pages |
August 2022
| by Isabelle Gagnon-Arpin, Isabella Moroz, Nicholas Moroz, Chad Leaver
|
|
|
|
|
|
|
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achat qui répond au défi épineux d'améliorer les soins et les résultats pour les...
Le Conference Board du Canada | 15 pages |
August 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
|
|
|
|
|
|
|
Interprovincial disparities in cancer outcomes persist. This primer explores the potential drivers of these disparities and how we can ensure every Canadian has a chance for the...
The Conference Board of Canada | 32 pages |
July 2022
| by Sarah Lussier Hoskyn, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Les disparités interprovinciales en matière de cancer persistent. Ce condensé explore les facteurs à l’origine de ces disparités et les façons de nous assurer que chaque Canadien...
Le Conference Board du Canada | 36 pages |
July 2022
| by Sarah Lussier Hoskyn, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems...
The Conference Board of Canada | 2 pages |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
La maladie d'Alzheimer est une préoccupation croissante au Canada. Les progrès scientifiques éclairent davantage sa pathologie et ouvrent les portes à de nouveaux traitements...
Le Conference Board du Canada | 2 pages |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems...
The Conference Board of Canada | Website |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
La maladie d’Alzheimer est un sujet de préoccupation grandissante au Canada. Les progrès scientifiques permettent de mieux comprendre sa pathologie et ouvrent la voie à de nouveaux...
Le Conference Board du Canada | Website |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
This briefing looks at potential life years and economic value gained from breakthrough cancer therapies. Gaps in patients’ access to these treatments means lost economic value...
The Conference Board of Canada | 16 pages |
February 2022
| by Kiefer Van Mulligen, Isabella Moroz, Chad Leaver
|
|
|
|
|
|
|
Ce rapport examine les années potentielles de vie et la valeur économique gagnées grâce aux traitements de pointe contre le cancer. Le fossé en matière d’accès des patients à ces...
Le Conference Board du Canada | 17 pages |
February 2022
| by Kiefer Van Mulligen, Isabella Moroz, Chad Leaver
|
|
|
|
|
|
|
La maladie d’Alzheimer est un sujet de préoccupation grandissante au Canada. Les progrès scientifiques permettent de mieux comprendre sa pathologie et ouvrent la voie à de nouveaux...
Le Conference Board du Canada | 45 pages |
January 2022
| by Isabella Moroz, Chad Leaver
|
|
|
|
|
|
|
Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems...
The Conference Board of Canada | 39 pages |
January 2022
| by Isabella Moroz, Chad Leaver
|
|
|
|
|
|
|
Canadian health leaders joined a roundtable discussion and examined ways to reform the health system to increase resiliency and address fragilities exposed by the COVID pandemic.
The Conference Board of Canada | 15 pages |
March 2021
| by Isabella Moroz, Monika Slovinec D’Angelo
|
|
|
|
|
|
|
This impact paper examines the optimized approach for the diagnosis and molecular testing of lung cancer developed by the Quebec Heart and Lung Institute—the Institut universitaire...
The Conference Board of Canada | 25 pages |
January 2021
| by Isabella Moroz, Monika Slovinec D’Angelo
|
|
|
|
|
|
|
Value-based approaches to health system management and healthcare delivery are being explored in Canada. To be reflected in improved health outcomes and system efficiencies, strategic...
The Conference Board of Canada | 36 pages |
December 2020
| by Monika Slovinec D’Angelo, Isabella Moroz, Alexander Smith, David Barrett
|
|
|
|